T

TYRA

Tyra Biosciences, Inc.

10.86

0.38+3.63%
After Hours: 10.95  +0.09  +0.83%16:25 05/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

363.56M

225.86M

266.18M

306.70M

16.01M

Total Current Assets

347.46M

211.67M

257.29M

304.06M

15.28M

Total Non Current Assets

16.09M

14.19M

8.89M

2.64M

730.00K

Total Liabilities

20.41M

21.59M

8.35M

4.96M

2.00M

Total Current Liabilities

14.59M

15.33M

5.70M

3.62M

1.86M

Total Non Current Liabilities

5.81M

6.26M

2.65M

1.35M

140.00K

Total Equity

343.15M

204.26M

257.83M

301.74M

14.01M

Total Stockholders Equity

343.15M

204.26M

257.83M

301.74M

14.01M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

363.56M

225.86M

266.18M

306.70M

16.01M

Total Common Shares Outstanding

50.75M

43.02M

42.35M

41.44M

39.40M

Total Preferred Shares Outstanding

--

--

--

--

--